Search

Search Results

• 

  Systemic sclerosis sine scleroderma: a case report of anterior uveitis

  T. Borges, J. Vilaça, S. Ferreira, I. Chora, S. Silva, C. Dias

  21-25

  30-06-2015

  https://doi.org/10.4081/reumatismo.2015.818

  2066

  PDF: 1058
• 

  Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center

  S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri

  158-165

  19-07-2012

  https://doi.org/10.4081/reumatismo.2012.158

  1060

  PDF: 834
• 

  Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline

  M. Colaci, D. Giuggioli, M. Sebastiani, A. Manfredi, F. Lumetti, F. Luppi, S. Cerri, C. Ferri

  149-155

  23-05-2016

  https://doi.org/10.4081/reumatismo.2015.837

  1934

  PDF: 1602

• The subclinical involvement of the lung in rheumatoid arthritis: evaluation by high-resolution computed tomography

  M. Carotti, F. Salaffi, P. Manganelli, L. Salvolini, E. Bichi Secchi, S. De Berardinis

  280-288

  https://doi.org/10.4081/reumatismo.2001.280

  1147

  PDF: 1555
• 

  Acute heart failure and rhabdomyolysis: a clue for the diagnosis of polymyositis with cardiac involvement

  P. Pinto-Lopes, L. Carneiro-Leão, R. Morais, J. Pinheiro, A. Vieira Lopes, P. Bettencourt

  78-83

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.924

  2068

  PDF: 968
• 

  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

  S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

  78-84

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1011

  2547

  PDF: 1337

• Cardiac involvement in rheumatoid arthritis

  M. Turiel, S. Sitia, L. Tomasoni, S. Cicala, F. Atzeni, L. Gianturco, M. Longhi, V. De Gennaro Colonna, P. Sarzi-Puttini

  244-253

  https://doi.org/10.4081/reumatismo.2009.244

  1943

  PDF: 1347
• 

  Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

  Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

  29-01-2025

  https://doi.org/10.4081/reumatismo.2025.1754

  1287

  PDF: 74

  SUPPLEMENTARY MATERIAL: 94

• Efficacy of immunosoppressive therapy and steroid sparing effect in interstitial lung disease associated to antisynthetase syndrome

  N. Franzolini, L. Quartuccio, G. De Marchi, S. De Vita

  202-208

  https://doi.org/10.4081/reumatismo.2007.202

  1409

  PDF: 1254

• HLA typing in systemic sclerosis

  E. Favalli, F. Ingegnoli, S. Zeni, M. Faré, F. Fantini

  210-214

  https://doi.org/10.4081/reumatismo.2001.210

  3108

  PDF: 5602

• Therapy of systemic sclerosis

  G. Valentini

  1-8

  https://doi.org/10.4081/reumatismo.2004.1

  1026

  PDF: 2266